Metabolomics Market to Reflect Significant Incremental Opportunity During 2017-2022
Various analytical approaches have been considered to study metabolites in different organisms, tissues, or fluids. There are wide application prospects of metabolomics such as phenotyping of genetically-modified plants and significant equivalence testing, determining gene function, and screening responses to biotic and abiotic stress. With these application in metabolism development, demand for metabolomics is especially high across developed countries. Metabolomics is very essential in research and development of any therapeutic drugs, which provide complete picture of a cell function, apart from identification of modifications in metabolites. The importance of metabolomics is likely to increase further as screening and data gathering of metabolomics data records and its metadata can lead to various theories and various objectives in biotechnology.
Metabolomics is a biological study of chemical processes that involve metabolites. This is useful to identify and quantify cell metabolites with the support of sophisticated diagnostic technologies using of multi-variant approaches for procuring information, withdrawal, and analysis of facts. Metabolomics deliver a through functional evidence of the physiological state in a bacterium.
Wide range of application in research and development and therapeutic areas to boost growth of metabolomics market
Request a sample copy of this [email protected]
Biomarker discovery segment to be the largest share of the global metabolomics market
Government funding to boost growth of the metabolomics market
Regional segmentation of the metabolomics market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest market share in the market, mainly due to presence easy availability to technologically advanced products and the presence of a large number of leading metabolomics manufacturers in the U.S and Canada. Increased awareness regarding the numerous benefits of metabolomics has led various government agencies make major investments in research and development to further support growth of the novel approach. For instance, in 2012, the National Institutes of Health (NIH) invested US$14.3 million, and stated that it would potentially fund more than US$ 51.4 million over the following five years, which would be a fast-track move to support development of the emerging field of biomedical research known as metabolomics. The NIH has also invested US$ 7 million in the three regional centers of Comprehensive Metabolomics Resource Cores and invested US$ 2 million in Data Repository and Coordination Center. It further proposed to invest US$ 6 million over the following five years.
The global metabolomics market is segmented on the basis of metabolomics instruments, application, indication, and geography. On the basis of metabolomics instrument, the metabolomics market is segmented into separation technique and detection technique. The separation technique is further segmented into gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra-performance liquid chromatography. The detection technique is further segmented into nuclear magnetic resonance spectroscopy, mass spectrometry, and surface-based mass analysis. Metabolomics bioinformatics tools and services is further segmented into bioinformatics tools & database and bioinformatics services. On the basis of application, the metabolomics market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. On the basis of indication, the metabolomics market is segmented into cancer, cardiovascular disorders, neurological disorders, and others.
Launch of various separation techniques to fasten the process to identification and quantification of cellular metabolites and boost growth of the metabolomics market
Key players operating the metabolomics market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, Waters Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Inc., and Bruker Corporation, among others. Major companies in the market are continuously working on research and development on determination of gene function and improving its accuracy in diagnosing a disease. This is expected to pave way for major revenue generation in the metabolomics market revenue over that forecast period. For instance, Agilent Technologies, Inc launched a wide range of systems, software and technologies intended to improve both the speed and accuracy of mass spectrometry which will boost the market share of Agilent Technologies, Inc.
Get TOC For This [email protected]
You may be interested
Myeloproliferative Neoplasms Treatment Market – Current Trends and Future Opportunities by 2026Albert R - September 20, 2018
Coherent Market Insights added Latest Research Report titled “Myeloproliferative Neoplasms Treatment Market Insights by Manufacturers, Growth, Trends, Regions, Product Type and Application, Geography, Forecast to 2026” to…
Osteoarthritis Treatment Market – Competitive Insights, Significant Futuristic Trends and Opportunities 2026Albert R - September 20, 2018
Coherent Market Insights added Latest Research Report titled “Osteoarthritis Treatment Market Insights by Manufacturers, Growth, Trends, Regions, Product Type and Application, Geography, Forecast to 2026” to its…